DYRK1A inhibition suppresses STAT3/EGFR/Met signalling and sensitizes EGFR wild‐type NSCLC cells to AZD9291

por Li, Yang‐ling, Ding, Ke, Hu, Xiu, Wu, Lin‐wen, Zhou, Dong‐mei, Rao, Ming‐jun, Lin, Neng‐ming, Zhang, Chong
Publicado 2019

Shikonin sensitizes wild-type EGFR NSCLC cells to erlotinib and gefitinib therapy

por Li, Yang-Ling, Hu, Xiu, Li, Qing-Yu, Wang, Fei, Zhang, Bo, Ding, Ke, Tan, Bi-Qin, Lin, Neng-Ming, Zhang, Chong
Publicado 2018

DYRK1A suppression attenuates HIF-1α accumulation and enhances the anti-liver cancer effects of regorafenib and sorafenib under hypoxic conditions

por Zhang, Chong, Wu, Lin-Wen, Li, Zhi-Di, Zhang, Man-Man, Wu, Jie, Du, Fei-Hua, Zeng, Ling-Hui, Li, Yang-Ling
Publicado 2022

DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD

por Li, Yang-ling, Zhang, Man-man, Wu, Lin-wen, Liu, Ye-han, Zhang, Zuo-yan, Zeng, Ling-hui, Lin, Neng-ming, Zhang, Chong
Publicado 2022

Decreased INPP5B expression predicts poor prognosis in lung adenocarcinoma

por Deng, Jun, Lin, Xu, Li, Qi, Cai, Xiao-yu, Wu, Lin-wen, Wang, Wei, Zhang, Bo, Li, Yang-ling, Hu, Jian, Lin, Neng-ming
Publicado 2022

DSCC1 interacts with HSP90AB1 and promotes the progression of lung adenocarcinoma via regulating ER stress

por Lin, Xu, Liu, Ye-han, Zhang, Huan-qi, Wu, Lin-wen, Li, Qi, Deng, Jun, Zhang, Qingyi, Yang, Yuhong, Zhang, Chong, Li, Yang-ling, Hu, Jian
Publicado 2023

Deacetylisovaltratum disrupts microtubule dynamics and causes G(2)/M-phase arrest in human gastric cancer cells in vitro

por Zhang, Dan, Zhang, Bo, Zhou, Li-xin, Zhao, Jun, Yan, You-you, Li, Yang-ling, Zeng, Jian-mei, Wang, Lin-ling, Yang, Bo, Lin, Neng-ming
Publicado 2016